Richard Drake to Neoplasm Proteins
This is a "connection" page, showing publications Richard Drake has written about Neoplasm Proteins.
Connection Strength
2.021
-
Glycosylation and cancer: moving glycomics to the forefront. Adv Cancer Res. 2015; 126:1-10.
Score: 0.397
-
Altered glycosylation in prostate cancer. Adv Cancer Res. 2015; 126:345-82.
Score: 0.397
-
Unique to this volume is the subsequent focus of individual chapters on what is known about glycosylation in relation to specific organ sites of cancer. Preface. Adv Cancer Res. 2015; 126:xiii-xiv.
Score: 0.394
-
Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg. 2009 May; 208(5):970-8; discussion 978-80.
Score: 0.264
-
Identification of reproducible low mass SELDI protein profiles specific to cisplatin resistance in human ovarian cancer cells. Oncol Rep. 2005 Nov; 14(5):1323-30.
Score: 0.209
-
Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry. Prostate. 2020 09; 80(13):1071-1086.
Score: 0.145
-
Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer. Oncotarget. 2015 Dec 22; 6(41):43743-58.
Score: 0.105
-
MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma. Proteomics. 2014 Apr; 14(7-8):924-35.
Score: 0.093
-
Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer. Mol Cell Proteomics. 2011 Jun; 10(6):M110.007294.
Score: 0.019